Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Virginia Villaverde"'
Autor:
Inés Pérez-Sancristóbal, Eduardo de la Fuente, María Paula Álvarez-Hernández, Kissy Guevara-Hoyer, Concepción Morado, Cristina Martínez-Prada, Dalifer Freites-Nuñez, Virginia Villaverde, Miguel Fernández-Arquero, Benjamín Fernández-Gutiérrez, Silvia Sánchez-Ramón, Gloria Candelas
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1168 (2023)
Introduction: We have previously shown that trained-immunity-based vaccines, namely TIbV, significantly reduce the rate of recurrent infections, both of the respiratory tract (RRTI) and urinary tract infections (RUTI) in SAD patients on disease-modif
Externí odkaz:
https://doaj.org/article/a6f59c94be6b47daa540bb56759d9a1a
Autor:
Silvia Sánchez-Ramón, Lidia Fernández-Paredes, Paula Saz-Leal, Carmen M. Diez-Rivero, Juliana Ochoa-Grullón, Concepción Morado, Pilar Macarrón, Cristina Martínez, Virginia Villaverde, Antonia Rodríguez de la Peña, Laura Conejero, Keyla Hernández-Llano, Gustavo Cordero, Miguel Fernández-Arquero, Benjamin Fernández- Gutierrez, Gloria Candelas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
IntroductionConventional or biologic disease-modifying anti-rheumatic drugs (DMARDs) are the mainstay of treatment for systemic autoimmune disease (SAD). Infectious complications are a major concern in their use.ObjectiveTo evaluate the clinical bene
Externí odkaz:
https://doaj.org/article/71b32669787c4d8dae48fc9b1ab127f2
Autor:
Santos Castañeda, María Rodero, Virginia Villaverde, M.C. Castro, Milena Gobbo, Amparo López Esteban, Carmen Suárez, Cristina Lajas Petisco, Juan Carlos Obaya, Leticia Leon, Juan Carlos Torre-Alonso, Fernando Jirout, Laly Alcaide, Carlos González, Juan Carlos Hermosa, Silvia García
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
instname
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Objective: To develop and assess the feasibility in daily practice of four comorbidity checklists, for common use in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). Methods: A multidisciplinary panel of exper
Autor:
Álvaro García Martos, Raquel Almodóvar, Estíbaliz Loza, Alejandro Prada, Pedro Zarco, Esther Rodríguez Almaraz, Virginia Villaverde, Elena Rabadán, Sheila Melchor, Beatriz Joven, Laura Cebrián Méndez, Victoria Navarro-Compán, Teresa Navío, Leticia Lojo Oliveira, Laura Zamudio González
Publikováno v:
Reumatología Clínica. 17:392-396
espanolObjetivo Analizar y comparar los cambios en la recogida de variables clinicas tras la implementacion en la practica diaria de un checklist de evaluacion para pacientes con espondiloartritis axial (EspAax) y artritis psoriasica (APs). Metodos S
Autor:
Teresa Navío, Raquel Almodóvar, Elena Rabadán, Beatriz Joven, Victoria Navarro-Compán, Virginia Villaverde, Leticia Lojo Oliveira, Pedro Zarco, Laura Cebrián Méndez, Sheila Melchor, Laura Zamudio González, Estíbaliz Loza, Alejandro Prada, Álvaro García Martos, Esther Rodríguez Almaraz
Publikováno v:
Reumatología Clínica (English Edition). 17:392-396
Objective To analyse and compare changes in the collection of clinical variables after the implementation in daily practice of an evaluation checklist for patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). Methods An observa
Autor:
Susana Gómez, Ana M. Ortiz, Virginia Villaverde, M. Valderrama, María Montoro, José Ramón Maneiro, Miguel Ángel Abad, Gloria Candelas, Lucía Silva Fernández
Publikováno v:
Rheumatology International. 41:57-66
To identify recommendations on the diagnosis and management of rheumatoid arthritis (RA) supported by low recommendation grades, to study the causes of this low grading, and to propose solutions. A group of six rheumatologists, with extensive experie
Autor:
Virginia Villaverde, Pilar Macarrón, Gustavo Cordero, Lidia Fernández-Paredes, Concepción Morado, Silvia Sánchez-Ramón, Cristina Martinez, Miguel Fernández-Arquero, Paula Saz-Leal, Antonia Rodríguez de la Peña, Carmen M. Diez-Rivero, Gloria Candelas, L. Conejero, Keyla Hernández-Llano, Juliana Ochoa-Grullón, Benjamin Fernández Gutierrez
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
IntroductionConventional or biologic disease-modifying anti-rheumatic drugs (DMARDs) are the mainstay of treatment for systemic autoimmune disease (SAD). Infectious complications are a major concern in their use.ObjectiveTo evaluate the clinical bene
Autor:
Silvia García, Juan Carlos Obaya, Juan Carlos Hermosa, Juan Carlos Torre-Alonso, Carmen Suárez, Virginia Villaverde, Carlos González, Amparo López Esteban, Laly Alcaide, Leticia Leon, Milena Gobbo, María Rodero, Santos Castañeda, Cristina Lajas Petisco, M.C. Castro, Fernando Jirout
Publikováno v:
Reumatologia clinica. 18(2)
Objective To develop and assess the feasibility in daily practice of four comorbidity checklists, for common use in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA). Methods A multidisciplinary panel of experts
Autor:
M Carlos. González, Santos Castañeda, Juan Carlos Torre-Alonso, María del Carmen Castro Villegas, María Rodero, Silvia Garcia-Diaz, Juan Carlos Hermosa, Leticia Leon, Juan Carlos Obaya, Virginia Villaverde, Cristina Lajas, Carmen Suárez
Publikováno v:
Abstracts Accepted for Publication.
Background The impact of comorbidity on the diagnosis, prognosis, and treatment of rheumatic diseases could be very high. However, several studies have depicted a sub-optimal assessment of comorbidity in these diseases. Objectives To generate common,
Autor:
María Espinosa, J. Quirós, Virginia Villaverde, Concepción Morado Quiroga, M. Peña, Jose Luis Morell Hita, Elia Pérez-Fernández, Ramón Mazzucchelli, Hilda Godoy, Cristina Macía-Villa, Carmen Barbadillo, A. García-Vadillo, Natalia Crespí-Villarías, Cristina Martinez-Prada, María Galindo-Izquierdo, M. Fernandez-Prada, Angeles Herranz Varela
Publikováno v:
Poster Presentations.
Background Treatment with biological agents is recognized as a potential risk factor for the development of Progressive Multifocal Leukoencephalopathy (PML), a rare and often fatal demyelinating disease of the CNS caused by John Cunningham Virus infe